Navigation Links
Protox Announces Positive Clinical Data from Prostate Cancer Study

development. A Phase 2a clinical trial evaluating PRX321 (INxin) for the treatment of primary brain cancer has been completed and the product candidate has received Fast Track Designation and Orphan Drug Status from the US FDA. In addition, a Phase 1 clinical trial evaluating PRX321 for the treatment of patients with renal cell carcinoma and non-small cell lung cancer has been completed. Patient enrollment has been completed for a Phase 1 clinical trial evaluating PRX302 (PORxin) for the treatment of localized prostate cancer. A Phase 1 clinical trial evaluating PRX302 for the treatment of benign prostatic hyperplasia (enlarged prostate) is ongoing.

NO REGULATORY AUTHORITY HAS APPROVED OR DISAPPROVED THE CONTENT OF THIS RELEASE. THE TSX VENTURE EXCHANGE DOES NOT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Certain statements included in this press release may be considered forward-looking. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements, and therefore these statements should not be read as guarantees of future performance or results. All forward-looking statements are based on Protox' current beliefs as well as assumptions made by and information currently available to Protox and relate to, among other things, anticipated financial performance, business prospects, strategies, regulatory developments, market acceptance and future commitments. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Due to risks and uncertainties, including the risks and uncertainties identified by Protox in its public securities filings; actual events may differ materially from current expectations. Protox disclaims any intention or obligation to update or revise any forward-lookin
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Protox Announces Publication in Journal of the National Cancer Institute Supporting PRX302 as Treatment for Prostatic Diseases
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:3/3/2015)... March 3, 2015   ... 240 patients respectively Publications in peer reviewed ... Clinical Gastroenterology highlight diagnostic value of confocal laser ... China and across Asia ... (Euronext: MKEA, FR0010609263), inventor of Cellvizio®, the multidisciplinary confocal ...
(Date:3/3/2015)... March 3, 2015  American Biosurgical, LLC ("ABI") ... cable manufacturer actively engaged in the design, development ... the world,s leading medical device companies has announced ... low volume custom medical cable manufacturer based in ... MTI brand under the name MTI Medical Cables.  ...
(Date:3/3/2015)... BOSTON , March 3, 2015  Columbia Laboratories, ... " or "the Company"), a specialty pharmaceutical company ... it will present at the 27th Annual ROTH Conference, ... Ritz-Carlton Laguna Niguel in Dana Point, California ... March 11 at 9:00 a.m. Pacific Time (12:00 p.m. ...
Breaking Medicine Technology:Two New Publications From Leading Team in China Present Data From Large Clinical Trials Highlighting Advantages of Cellvizio in Diagnosis of Gastric and Esophageal Cancers 2Two New Publications From Leading Team in China Present Data From Large Clinical Trials Highlighting Advantages of Cellvizio in Diagnosis of Gastric and Esophageal Cancers 3Two New Publications From Leading Team in China Present Data From Large Clinical Trials Highlighting Advantages of Cellvizio in Diagnosis of Gastric and Esophageal Cancers 4American Biosurgical Acquires MTI Corporation 2
... America, Inc., a global leader in medical diagnostic ... its selection to Center for Companies That Care,s ... of Human Resources, Sysmex America.  As a 2012 ... its outstanding workplace practices and active community involvement.  ...
... 16, 2012  Sanofi (EURONEXT: SAN and NYSE: ... have entered into a definitive agreement under which Sanofi ... based in Woburn, Massachusetts.  The acquisition is subject to ... ) Pluromed has developed a proprietary ...
Cached Medicine Technology:Sysmex America Earns 4th Consecutive Placement on Companies That Care Honor Roll 2Sanofi to Acquire Pluromed, Inc., Expanding Its Presence in Biosurgery 2Sanofi to Acquire Pluromed, Inc., Expanding Its Presence in Biosurgery 3Sanofi to Acquire Pluromed, Inc., Expanding Its Presence in Biosurgery 4
(Date:3/3/2015)... New York, NY (PRWEB) March 03, 2015 ... sleepy this spring. Sanjeev Kothare, MD, has tips for parents. ... tired come March 8 at 2:00 a.m. when they set ... because when you wake up that day -- one hour ... sleep. , That’s why parents should start thinking about “sleep ...
(Date:3/3/2015)... 03, 2015 Sunday, March 1, through Saturday, ... the time of year, every region of the country is ... why Amica Insurance is sharing the following tips ... to help keep you safe in the event of severe ... Change wet clothing frequently to prevent loss of body heat. ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 -- vRad ( Virtual ... practice, today announced that Arlene Sussman, MD, a highly ... a live webinar to explore how telemedicine best practices ... imaging services for women virtually anywhere. Click here ... Service Line” on March 4, 2015 at 1:00 pm ...
(Date:3/3/2015)... Splashtop Inc. , the worldwide leader ... available for Epson® MoverioTM BT-200 smart glasses. ... Market , iPod, iPhone, and iPad users can now ... Moverio smart glasses using Mirroring360, enhancing the user experience ... Epson smart glasses have an advanced binocular optical system ...
(Date:3/3/2015)... March 03, 2015 According to ... http://www.idataresearch.com ), market saturation has made neurosurgery navigation ... the United States. Unit sales growth moderately increased ... as facilities replace older systems, and as new ... market is very much a replacement and upgrade ...
Breaking Medicine News(10 mins):Health News:Don’t Let Daylight Savings Disrupt Your Child’s Sleep 2Health News:Amica Insurance Has Tips for National Severe Weather Preparedness Week 2Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 2Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 3Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 4Health News:Splashtop’s Mirroring360 Now Available for Epson® MoverioTM BT-200 Smart Glasses, Enabling Viewing of iOS Apps and Content on Glasses 2Health News:Splashtop’s Mirroring360 Now Available for Epson® MoverioTM BT-200 Smart Glasses, Enabling Viewing of iOS Apps and Content on Glasses 3Health News:Neurosurgery Navigation System Market Reaches Saturation in the United States 2Health News:Neurosurgery Navigation System Market Reaches Saturation in the United States 3
... Adds Depth to Management Team, BIRMINGHAM, Ala., ... a leader in enterprise medical information technology,systems for ... Chris,E. Perkins has been named Chief Operating Officer. ... at Per-Se Technologies,where he served in senior executive ...
... procedure to be held Thursday, January 17, at ... 3:00 p.m. ... Inc.,(Nasdaq: CRDC ) today announced that leading cardiac surgeons from ... a live off-pump coronary artery bypass graft (CABG) procedure as,well as ...
... children facing their own altered reality, experts say , , MONDAY, ... them of the life they once knew, some people can ... cases -- as highlighted by recent news on retired Supreme ... of the Alzheimer,s patient grows to understand and accept the ...
... --,HearAtLast Holdings, Inc. is proud to announce that it ... WMT ) to open its 16th hearing-aid,clinic to be ... Linden,Dr. in Richmond Hill, Ontario. The new clinic officially ... expansion is a direct result of,the Company exercising its ...
... From One Proxy Advisory Firm, MONTVALE, N.J., ... today issued a statement strongly recommending shareholders,re-elect Datascope,s ... William,L. Asmundson - and reject Ramius Capital,s opposition ... Annual Meeting of Shareholders., Robert Klatell, Chairman ...
... new study finds significant underuse of colorectal cancer screening ... January 15, 2008 issue of CANCER, a peer-reviewed journal ... percent of Medicare patients received recommended screening during the ... leading cause of cancer death in both men and ...
Cached Medicine News:Health News:Emageon Names Chris E. Perkins as Chief Operating Officer 2Health News:Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery 2Health News:Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery 3Health News:Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery 4Health News:Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery 5Health News: Love in the World of Alzheimer's 2Health News: Love in the World of Alzheimer's 3Health News:HearAtLast Continues Expansion Announcing Opening of New Clinic Location in Sam's Club in Richmond Hill, Ontario 2Health News:HearAtLast Continues Expansion Announcing Opening of New Clinic Location in Sam's Club in Richmond Hill, Ontario 3Health News:HearAtLast Continues Expansion Announcing Opening of New Clinic Location in Sam's Club in Richmond Hill, Ontario 4Health News:Datascope Recommends Shareholders Re-Elect its Two Incumbent Directors and Reject Ramius' Opposition Slate 2Health News:Datascope Recommends Shareholders Re-Elect its Two Incumbent Directors and Reject Ramius' Opposition Slate 3Health News:Datascope Recommends Shareholders Re-Elect its Two Incumbent Directors and Reject Ramius' Opposition Slate 4Health News:Datascope Recommends Shareholders Re-Elect its Two Incumbent Directors and Reject Ramius' Opposition Slate 5Health News:Many Medicare beneficiaries not receiving colorectal cancer screening 2
... design of the LONGLIFE P-O-C ... modern configuration, now with a ... complement any office decor. The ... integrate into existing practices, offering ...
The Onar®Lp -QP test system is an in vitro test for the quantitative diagnosis of legionella in clinical samples....
The VPAP III is a complete system solution for sleep-disordered breathing (SDB), providing comfortable and effective bilevel treatment. The VPAP III is an effective business solution for clinicians, ...
... Polyacrylamide gel Electrophoresis Method for the ... all Lipoprotein Fractions and Subfractions, ,The ... diagnostic test for cholesterol components which ... methods. The Lipoprint test provides detailed ...
Medicine Products: